Illuminating the cross-talk between tumor metabolism and immunity in IDH-mutated cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Illuminating the cross-talk between tumor metabolism and immunity in IDH-mutated cancers

Published:2021-04 Issue: Volume:68 Page:181-185
ISSN:0958-1669
Container-title:Current Opinion in Biotechnology
language:en
Short-container-title:Current Opinion in Biotechnology

Author:

Leca Julie,Fortin Jerome,Mak Tak W

Funder

Cancer Research Institute

Cancer Research Society

Leukemia and Lymphoma Society

Canadian Institutes of Health Research

Publisher

Elsevier BV

Subject

Biomedical Engineering,Bioengineering,Biotechnology

Reference51 articles.

1. Oncogenic isocitrate dehydrogenase mutations: mechanisms, models, and clinical opportunities;Cairns;Cancer Discov,2013

2. IDH2 mutation analysis in undifferentiated and poorly differentiated sinonasal carcinomas for diagnosis and clinical management;Riobello;Am J Surg Pathol,2020

3. Cancer-associated mutation and beyond: the emerging biology of isocitrate dehydrogenases in human disease;Tommasini-Ghelfi;Sci Adv,2019

4. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate;Dang;Nature,2009

5. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases;Xu;Cancer Cell,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism and epigenetics: drivers of tumor cell plasticity and treatment outcomes;Trends in Cancer;2024-09

2. The Cancer Antioxidant Regulation System in Therapeutic Resistance;Antioxidants;2024-06-27

3. Dependence on mitochondrial respiration of malignant T cells reveals a new therapeutic target for angioimmunoblastic T-cell lymphoma;Cell Death Discovery;2024-06-19

4. IDH mutation, glioma immunogenicity, and therapeutic challenge of primary mismatch repair deficient IDH‐mutant astrocytoma PMMRDIA: a systematic review;Molecular Oncology;2024-02-09

5. TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma;Medicine;2023-12-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3